Resources
-
Developability Risk Assessment for Dual Variable Domain Immunoglobulin (DVD-Ig™)
Speaker Presentation Filoti Dana, AbbVie Bioresearch Center, Inc., 2021
-
NMR Based Similarity Metrics for Higher Order Structure Assessment Among U.S. Marketed Insulin Drug Products
Speaker Presentation Chen Kang, CDER, FDA, 2021
-
The Unfolded State of Proteins Viewed with Time-resolved FRET, Unnatural Amino Acids and Microfluidic Mixing
Speaker Presentation Bilsel Osman, Microgradient Fluidics LLC, 2021
-
Dynamics of IgG1 Glycoforms and Interaction With FcγR1
Speaker Presentation Anderson Kyle, National Institute of Standards and Technology (NIST), 2021
-
Breakthroughs That Change Patients' Lives -- Development and Optimization of a LabChip® Method for Characterization of a Heavily Sialylated Protein and Its Advantage in High-Throughput InProcess Development Support
Speaker Presentation Yu Qing, Pfizer Inc., 2020
-
A Holistic Strategy to Characterize the In Vivo Stability of Novel Modalities Using Affinity Capture Coupled to LC-MS or CE-Based Methods
Speaker Presentation Wu Cong, Genentech, a Member of the Roche Group, 2020
-
Clinical Diagnostics of Transferrin Glycoforms by High-resolution CE
Speaker Presentation Thormann Wolfgang, University of Bern, 2020
-
The Role of Quality Systems and Quality Culture in CE Life-Cycle Management
Speaker Presentation Swann Patrick, CSL Behring, 2020
-
Recent Trends in the Regulation of Biopharmaceuticals in Korea
Speaker Presentation Kim Jina, Ministry of Food and Drug Saftey (MFDS), 2020
-
Methionine Oxidation Analyzed by ACE
Speaker Presentation Hutanu Andrei, Basel University/ F. Hoffmann-La Roche Ltd., 2020
-
Bioanalytical Characterization and Separation of Dengue Virus
Speaker Presentation Gattu Srikanth, Merck & Co., Inc., 2020
-
Integrating Mass Spectrometry-Based Footprinting Approaches and Molecular Docking for Protein Binding Interfaces Analysis
Speaker Presentation Zhang Mengru, Seagen Inc., 2020
-
Mass Spectrometry Based Higher Order Structure Characterization -- Applications in Design, Optimization and Development of Protein Therapeutics
Speaker Presentation Zhang Jun, Amgen Inc., 2020
-
Regulatory Suggestions for MS Characterization of Newer Modalities Such as GTx and mRNA
Roundtable 11 Notes: Mass Spec 2020
-
MS of Oligonucleotides: Minimizing Adducts and Quantitation Best Practices
Roundtable 10 Notes: Mass Spec 2020
-
Multi-Omic Cheracterization of CHO Media and Lysate During the Production of Biotherapeutics
Speaker Presentation Weisenhorn Erin, Just-Evotec Biologics, 2020
-
Regulatory Considerations for MultiAttribute Method Implementation
Speaker Presentation Wang Xiaoshi, CDER, FDA, 2020
-
Software Analysis of MS Data: Emerging Approaches and Best Practices
Roundtable 9 Notes: Mass Spec 2020
-
Precision Medicine – The Analytical Pipeline Behind Patient Remote Blood Sampling
Speaker Presentation Van Eyk Jennifer, Cedars-Sinai Medical Center, 2020
-
New Developments in MS Analysis of Released N- and O-glycans
Roundtable 8 Notes: Mass Spec 2020